Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/8/11/1159/19480335/8-11-1159.pdf
Reference18 articles.
1. Doxorubicin (or epidoxor-ubicin) combined with ifosasfamide in the treatment of adult soft tissue sarcomas;Toma;Ann Oncol,1993
2. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft-tissue sarcomas: A randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group;Santoro;J Clin Oncol,1995
3. Bone marrow autotransplantation for solid tumors-prospects;Frei;J Clin Oncol,1989
4. Ifosfamide plus mesna with and without Adriamycin in soft tissue sarcomas;Wiltshaw;Cancer Chemother Pharmacol,1986
5. Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcomas;Antman;J Clin Oncol,1989
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. UK guidelines for the management of soft tissue sarcomas;British Journal of Cancer;2024-05-11
2. Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG);Cancer Management and Research;2022-09
3. Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma;Rare Tumors;2021-01
4. Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis;Cancers;2020-11-17
5. Is continuous infusion of high-dose ifosfamide, a safe option? Drug review;International Journal of Molecular & Immuno Oncology;2020-05-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3